Efficacy of Concerta vs Vyvanse in Women with ADHD

Evidence-Based Efficacy Comparison

The American Academy of Child and Adolescent Psychiatry recommends that amphetamines, such as Vyvanse, achieve larger effect sizes (SMD -0.79) compared to methylphenidate (SMD -0.49) for clinician-rated ADHD core symptoms in adults 1
Network meta-analysis of over 10,000 children and adolescents revealed no clinically significant superiority of one stimulant class over the other in this age group, with methylphenidate showing SMD -0.78 and amphetamines SMD -1.02 on clinician ratings 2
Approximately 40% of patients respond to only one stimulant type, with overall response rates approaching 90% when both classes are tried sequentially 1

Concerta provides 12-hour coverage, the longest duration among methylphenidate formulations, and causes significantly less sleep disruption compared to amphetamines like Vyvanse 2
Vyvanse provides the longest duration of any stimulant at 13-14 hours, extending beyond typical school/work hours and addressing functional impairment across multiple settings 1, 2

For adult women, the treatment guidelines recommend starting with Vyvanse 20-30 mg once daily in the morning, titrating by 10-20 mg weekly up to 70 mg maximum based on response 1
If no desired benefit after adequate treatment with one stimulant class, switch to the other class before considering non-stimulants, as approximately 40% of patients respond to only one stimulant type 1, 3

Regular monitoring of blood pressure and pulse at baseline and during treatment for both medications is recommended 1, 2
Height and weight monitoring, as well as evaluation of sleep disturbances and appetite changes, are also necessary 1, 2

Amphetamines typically cause greater effects on appetite and sleep due to longer excretion half-lives, requiring more aggressive management of these side effects 1
Both medications are contraindicated in active stimulant abuse, symptomatic cardiovascular disease, and uncontrolled hypertension 1